ReviewFrontiers in immunology2017

MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic.

Jesus Gonzalo-Asensio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.